Management of Widespread Pain and Fibromyalgia
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Proposed genealogies of the syndrome now known as fibromyalgia (FM) stretch back as far as the late sixteenth century [ 1 ]. Key historical moments in its emergence as a distinct entity include the 1904 debut of fibrositis [ 2 ] and Hench’s introduction of the term “fibromyalgia” in 1976 [ 3 ]. The American College of Rheumatology (ACR) first published classification criteria in 1990 [ 4 ••], characterizing FM as chronic widespread pain (pain in the axial skeleton and on both sides of the body, above and below the waist, for at least 3 months), plus 11 out of a possible 18 tender points on clinical examination. The ACR disseminated revised criteria in 2010, the update shifting the emphasis from classification to diagnosis [ 5 ••]. The tender point requirement was replaced by recognition of the importance of patient-reported symptoms, including somatic, cognitive, and mood disorders. The revised criteria allowed FM to be measured on a continuous scale that incorporated the widespread-ness of pain and the severity of concurrent symptoms. A modified version of the 2010 criteria was published a year later (2011), and these were used to develop a questionnaire for use in clinical and epidemiological studies of the syndrome [ 6 ••]. The mean worldwide prevalence of FM has been estimated to be 2.7 %, with a higher occurrence in women and those of middle or older age and lower socioeconomic status [ 7 ]. US prevalence has been estimated as 2.2 % using the 1990 ACR criteria [ 8 ] and 6.4 % using the 2010 ACR criteria [ 9 ]. Advances in the understanding of the underlying pathophysiology, including recognition of the role of central pain sensitization, have informed FM management. Findings from studies investigating pharmacological, non-pharmacological and complementary, and alternative therapies have been summarized in clinical practice guidelines (CPG). These include The European League Against Rheumatism’s (EULAR) appraisal of the literature, published in 2008 [ 10 •], which is currently being updated. This document was one of six CPGs that contributed to a systematic review of guidelines published up to 2014 [ 11 ••] which forms the basis of the evidence provided below.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The management of FM is challenging, with limited effectiveness shown by pharmacological therapies [48,49,50,51].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Anticonvulsants for fibromyalgia
Üçeyler, N., Sommer, C., Walitt, B., & Häuser, W. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010782 · Cited by 86
RetractedThe american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Psychosomatic medicine in Germany: more timely than ever
Zipfel, S., Herzog, W., Kruse, J., & Henningsen, P. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447701 · Cited by 2,323
Fibromyalgia: A Clinical Review
Clauw, D. J. (2014) · JAMA · doi:10.1001/jama.2014.3266 · Cited by 1,674
WOLFE, F., CLAUW, D. J., FITZCHARLES, M.-A., GOLDENBERG, D. L., HÄUSER, W., KATZ, R. S., MEASE, P., RUSSELL, A. S., RUSSELL, I. J., & WINFIELD, J. B. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100594 · Cited by 1,499
Worldwide epidemiology of fibromyalgia
Queiroz, L. P. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0356-5 · Cited by 826
The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2783 · Cited by 814
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Cited by
The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders
Knezevic, E., Nenic, K., Milanovic, V., & Knezevic, N. N. (2023) · Cells · doi:10.3390/cells12232726 · Cited by 564
“The management of FM is challenging, with limited effectiveness shown by pharmacological therapies [48–51].”
BackgroundGeraghty, A. W. A., Maund, E., Newell, D., Santer, M., Everitt, H., Price, C., Pincus, T., Moore, M. V., Little, P. S., West, R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254642 · Cited by 76
“The reduced focus on pharmacological management in CWP [7, 8] aligns with the increasing importance placed on psychosocial and behavioural self-management for this complex pain condition [3, 6, 9].”
BackgroundToh, E. Y. J., Ng, J. S. P., McIntyre, R. S., Tran, B. X., Ho, R., Ho, C. S. H., & Tam, W. W. S. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001062 · Cited by 23
Fibromyalgia with Gabapentin and Osteopathic Manipulative Medicine: A Pilot Study
Marske, C., Bernard, N., Palacios, A., Wheeler, C., Preiss, B., Brown, M., Bhattacharya, S., & Klapstein, G. J. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0178 · Cited by 22
Begum, N., Taylor, J. R., Brown, C. A., Rajan, J. N., Keevil, B. G., Pye, E., Rainey, T., & Jones, A. K. P. (2021) · European Journal of Pain · doi:10.1002/ejp.1854 · Cited by 17
“FM is difficult to diagnose and manage, with pharmacological interventions demonstrating limited efficacy (Choy et al., 2010; Galvez- Sanchez & Del Paso, 2020; Häuser et al., 2018; Whibley et al., 2016).”
Background
Metadata
- Authors
- Whibley, D., Dean, L. E., & Basu, N.
- Affiliations
- University of Aberdeen (GB)
- Corresponding author
- Basu, Neil
- Venue
- Current Treatment Options in Rheumatology
- Published
- 2016-10-13
- Volume
- 2
- Issue
- 4
- Pages
- 312-320
- ISSN
- 2198-6002 (ISSN-L)
- PMC
- PMC5566487
- OpenAlex
- W2530406511
- Semantic Scholar
- 6ebd24d1afbb23725c310513d0eaa6f95cb49b45
- Cited by
- 23
- References
- 40
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 2 · 2021: 7 · 2019: 1 · 2018: 2
- FWCI
- 0.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Current Treatment Options in Rheumatology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Aberdeen University Research Archive (Aberdeen University) (submittedVersion)
- Funders
- University of Aberdeen
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Myofascial pain diagnosis and treatment
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- fibromyalgia, chronic widespread pain, fibromyalgia diagnosis, ACR classification criteria, prevalence, central sensitization, pathophysiology, pharmacotherapy, non-pharmacological treatment, complementary and alternative medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of Widespread Pain and Fibromyalgia. https://app.cochat.ai/papers/10.1007/s40674-016-0056-5
- The paper
- Whibley, D., Dean, L. E., & Basu, N. (2016). Management of Widespread Pain and Fibromyalgia. Current Treatment Options in Rheumatology. https://doi.org/10.1007/s40674-016-0056-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.